Search research articles
Contact Us
Filters
Showing results (531-540 of 575) with videos related to
Page
of 58
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer
Denise A Yardley, Robert Weaver, Michelle E Melisko, et al.
The Journal of Clinical Investigation
|
March 10, 2026
Impaired glycosylation promotes rapid transition to hepatocellular carcinoma in model of diet induced steatotic liver disease
Abhishek K Singh, Balkrishna Chaube, Kathryn M Citrin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2020
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Changqing Xie, Austin G Duffy, Gagandeep Brar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2021
Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Changqing Xie, Austin G Duffy, Gagandeep Brar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
Mark E Dudley, James C Yang, Richard Sherry, et al.
Radiology
|
July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI
Liza Lindenberg, Esther Mena, Baris Turkbey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
Daniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Trials
|
January 31, 2020
An integrated intervention for chronic care management in rural Nepal: protocol of a type 2 hybrid effectiveness-implementation study
Dan Schwarz, Santosh Dhungana, Anirudh Kumar, et al.
Page
of 58
Search research articles
Search
Showing results (531-540 of 575) with videos related to
Sort By:
Page
of 58
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer
Denise A Yardley, Robert Weaver, Michelle E Melisko, et al.
The Journal of Clinical Investigation
|
March 10, 2026
Impaired glycosylation promotes rapid transition to hepatocellular carcinoma in model of diet induced steatotic liver disease
Abhishek K Singh, Balkrishna Chaube, Kathryn M Citrin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2020
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Changqing Xie, Austin G Duffy, Gagandeep Brar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2021
Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Changqing Xie, Austin G Duffy, Gagandeep Brar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
Mark E Dudley, James C Yang, Richard Sherry, et al.
Radiology
|
July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI
Liza Lindenberg, Esther Mena, Baris Turkbey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
Daniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Trials
|
January 31, 2020
An integrated intervention for chronic care management in rural Nepal: protocol of a type 2 hybrid effectiveness-implementation study
Dan Schwarz, Santosh Dhungana, Anirudh Kumar, et al.
Page
of 58